A. Lo Monaco

TL;DR: Among patients with early diffuse cutaneous systemic sclerosis, HSCT was associated with increased treatment-related mortality in the first year after treatment, however, HCST conferred a significant long-term event-free survival benefit.

TL;DR: Clinical and roentgenological evaluation disclosed important clues to differentiate this condition from other more common distal interphalangeal arthritides—namely, osteoarthritis and its “erosive” variant, rheumatoid arthritis, psoriatic arthritis, tophaceous gout, dialysis related hand arthropathy, and from the rarer fibroblastic rheumatism, all of which can be mimicked by MRH.

TL;DR: Risk factors, clinical features, diagnostic work-up and outcome of patients developing VL under biologic therapy are described and its presence should always be suspected in patients developing a triad of signs and symptoms constituted by fluctuant fever, pancytopenia and splenomegaly, especially if coming from endemic areas.

TL;DR: The data suggest that SS may not directly cause sensorineural hearing loss, and no relationship was found between the duration of the disease and the DPOAE and hearing threshold variables.

TL;DR: The importance of adequate work-up in those patients presenting with serious clinical manifestations that can complicate, exacerbate or mimic a systemic connectivetissue disorder is highlighted.